ACELRX PHARMACEUTICALS INC (ACRX)
US00444T2096 - Common Stock
| TTM (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -21.36M | 47.76M | -35.10M | -40.38M | -53.24M | |||
| Depreciation Amortization | 650.00K | 1.65M | 1.97M | 1.85M | 1.67M | |||
| Change In Working Capital | -1.20M | -1.39M | 200.00K | -2.29M | -3.91M | |||
| Interest Paid | N/A | 820.00K | 1.60M | 2.27M | 1.71M | |||
| Taxes Paid | N/A | 10.00K | 10.00K | -350.00K | -350.00K | |||
| Other non cash items | 2.96M | -76.34M | 2.92M | 2.31M | 4.30M | |||
| OPERATING CASH FLOW | -18.95M | -28.33M | -30.00M | -38.51M | -51.18M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -140.00K | -360.00K | -1.83M | -1.86M | -3.47M | |||
| Other Investing Activity | 5.92M | 36.81M | -24.30M | 35.99M | -33.09M | |||
| INVESTING CASH FLOW | 5.78M | 36.45M | -26.12M | 34.14M | -36.56M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -7.60M | -8.43M | -8.83M | -4.67M | 21.53M | |||
| Stock Issued/Repurchased | 16.44M | 7.98M | 45.03M | 21.71M | 1.98M | |||
| Other Financing Activity | -20.00K | -60.00K | 5.31M | -90.00K | -9.05M | |||
| FINANCING CASH FLOW | 8.82M | -510.00K | 41.51M | 16.96M | 14.45M | |||
| CHANGE IN CASH | -4.35M | 7.61M | -14.61M | 12.59M | -73.29M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -18.95M | -28.33M | -30.00M | -38.51M | -51.18M | |||
| Capital Expenditure | -140.00K | -360.00K | -1.83M | -1.86M | -3.47M | |||
| FREE CASH FLOW | -19.09M | -28.69M | -31.83M | -40.37M | -54.65M | |||
All data in USD